Advertisement
UK markets closed
  • FTSE 100

    8,078.86
    +38.48 (+0.48%)
     
  • FTSE 250

    19,601.98
    -117.39 (-0.60%)
     
  • AIM

    753.12
    -1.57 (-0.21%)
     
  • GBP/EUR

    1.1654
    +0.0009 (+0.08%)
     
  • GBP/USD

    1.2492
    +0.0029 (+0.23%)
     
  • Bitcoin GBP

    51,287.23
    -548.52 (-1.06%)
     
  • CMC Crypto 200

    1,386.49
    +3.91 (+0.28%)
     
  • S&P 500

    5,017.55
    -54.08 (-1.07%)
     
  • DOW

    37,902.54
    -558.38 (-1.45%)
     
  • CRUDE OIL

    82.50
    -0.31 (-0.37%)
     
  • GOLD FUTURES

    2,342.20
    +3.80 (+0.16%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,917.28
    -171.42 (-0.95%)
     
  • CAC 40

    8,016.65
    -75.21 (-0.93%)
     

BUZZ-Top of the Street: Puma, Daimler, AB InBev, Fortum, Uniper

A round-up of notable broker activity this morning from Europe's top-ranked* analysts:

** Credit Suisse ups Puma to "neutral" from "underperform" as higher-than-expected sales growth offsets its prior concerns about costs

** Jefferies cuts Daimler to "underperform" from "hold" and Renault to "underperform" from "buy"; saying that both have unclear compliance roadmaps, below normal average earnings and balance sheet risk on potential cash burn

** Jefferies ups AB InBev to "hold" from "underperform" as the company pivots towards top-line driven model, accompanied by "a more balanced approach to growth between volumes and revenue per hectoliter"

ADVERTISEMENT

INITIATIONS AND REINSTATEMENTS

** Credit Suisse starts coverage of Fortum and Uniper with "outperform" and "neutral" respectively; saying it prefers Fortum over Uniper due to higher earnings growth and more attractive valuation

** Morgan Stanley resumes coverage of Ocado Group with "equal-weight", saying recent developments at Ocado have been taken well by the market, but these attractions appear largely priced in

(*Analyst rankings from Thomson Reuters StarMine. Scale is from 1-star to 5-star with 5 being best. Analysts ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.)